OTHER INFORMATION
−Removed: On May 12, 2021, the compensation committee of our board of directors granted 580,000 restricted stock units (“RSUs”) to R.
−Removed: Erik Holmlin, Ph.D., our President and Chief Executive Officer (the “Holmlin Grant”), and 240,000 RSUs to Mark Oldakowski, our Chief Operating Officer (the “Oldakowski Grant”), in each case with an effective grant date and vesting commencement date of May 12, 2021.
−Removed: 290,000 RSUs under the Holmlin Grant are subject to time-based vesting, with 50% of the shares vesting on each of the first and second anniversaries of the vesting commencement date, subject to continued service through the vesting date, and 18 months vesting acceleration upon a termination without cause or resignation with good reason.
−Removed: 290,000 RSUs under the Holmlin Grant are subject to vesting upon the satisfaction of certain specified revenue targets within four years following the vesting commencement date.
−Removed: Holmlin’s employment with the Company is terminated without cause or he resigns with good reason, then the shares will continue to be eligible for vesting upon satisfaction of the revenue targets within a period that is the shorter of 18 months following termination or four years following the vesting commencement date.
−Removed: The RSUs comprising the Oldakowski Grant are subject to time-based vesting, with 50% of the shares vesting on each of the first and second anniversaries of the vesting commencement date, subject to continued service through the vesting date.
Number Description
−Removed: Amended and Restated Certificate of Incorporation.
+Added: Amended and Restated Certificate of Incorporation, as amended.
Amended and Restated Bylaws.
8 unchanged sentences
Form of Warrant to Purchase Common Stock issued to Investors in October 2019 Public Offering.
−Removed: Fourth Amendment to the Lease by and between the Company and The Irvine Company LLC, dated February 15, 2021.
−Removed: Sales Agreement, dated March 23, 2021, by and between the Company and Cowen and Company, LLC.
+Added: 10.1 Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Bionano Genomics, Inc.
+Added: 2018 Equity Incentive Plan
31.1* Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
2 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101.INS XBRL Instance Document.
−Removed: 101.SCH XBRL Taxonomy Extension Schema Document.
−Removed: 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document.
−Removed: 101.DEF XBRL Taxonomy Extension Definition Linkbase Document.
−Removed: 101.LAB XBRL Taxonomy Extension Label Linkbase Document.
−Removed: 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document.
−Removed: (1) Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed with the SEC on August 24, 2018.
+Added: 101.INS Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document.
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema Document.
+Added: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
+Added: 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
+Added: 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
+Added: 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
+Added: 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
+Added: (1) Incorporated by reference to the Registrant’s Annual Report on Form 10-K, filed with the SEC on March 23, 2021.
(2) Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No.
4 unchanged sentences
333-233828), as amended.
−Removed: (6) Incorporated by reference to the Registrant’s Annual Report on Form 10-K, filed with the SEC on March 23, 2021.
−Removed: (7) Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed with the SEC on March 24, 2021.
* This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
1 unchanged sentence
BIONANO GENOMICS, INC.
+Added: August 4, 2021
Erik Holmlin, Ph.D.
2 unchanged sentences
(Principal Executive Officer)
+Added: August 4, 2021
/s/ Christopher Stewart
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.